FDA urges caution in weighing risks of ADHD drugs

WASHINGTON (AP) -- Federal health regulators are urging parents to keep their children on attention deficit drugs like Ritalin and Adderall, despite new evidence from a government-backed study that the stimulants can increase the risk of sudden death....

Read the whole article on AP Health

More from AP Health